The nontuberculous mycobacteria (NTM) include all mycobacteria species other than Mycobacterium tuberculosis and M. leprae.1 More than 190 NTM species and subspecies have been identified that can cause a wide range of clinical syndromes, most commonly pulmonary, skin and soft tissue, and device-associated infections, as well as lymphadenitis.1-3 NTM are opportunistic pathogens, placing certain groups, such